Patterson is a registered nurse and executive director of a consulting firm that supports OPTN contracts.

The reductions come as the federal government has asked other companies to do some of UNOS' work and as the federal Department of Health and Human Services has been told ...

March 26, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported financial ...

Shares of OptiNose (OPTN) have gained 58.6% over the past four weeks to close the last trading session at $9.15, but there could still be a solid upside left in the stock if short-term price ...

Claim your 7-day free trial now. OptiNose Inc OPTN shares are trading higher Thursday after Paratek Pharmaceuticals announced a deal to acquire the company. What Happened: Late Wednesday ...

OPTINOSE ($OPTN) posted quarterly earnings results on Wednesday, March 26th. The company reported earnings of -$0.03 per share, beating estimates of -$0.72 by $0.69 ...

OptiNose (OPTN) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.70. This compares to loss of $1.35 per share a year ago. These figures are ...